CytoSen Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
CytoSen Therapeutics, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CHANGING THE WORLD BILLIONS OF CELLS ATA TIME. The owner is based in Winter Springs, FL.
Suite 2001, Room 254
1511 E. State Road 434
Winter Springs, FL 32708
Showing of trademarks Trademarks
Trademark Classifications
CytoSen Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CytoSen Therapeutics, Inc. have?
CytoSen Therapeutics, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does CytoSen Therapeutics, Inc. file in?
CytoSen Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CytoSen Therapeutics, Inc.'s most well-known trademarks?
CytoSen Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as CHANGING THE WORLD BILLIONS OF CELLS ATA TIME. These are among 1 currently registered trademark in the portfolio.
What is CytoSen Therapeutics, Inc.'s trademark registration success rate?
CytoSen Therapeutics, Inc. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.